Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Gyros Protein Technologies
Gyros Protein Technologies
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency
Partnership complements Gyros’ PurePep EasyClean technology offering with an automated solution for advanced discovery process
Manufacturing
Gyros Protein Technologies introduces updated peptide synthesiser
The device introduces real-time flow technology, a non-invasive method designed to continually monitor the flow rate of fluids within the system
Manufacturing
Gyros Protein Technologies introduces Gyrolab AAV9 Titer kit
The kit is designed to support AAV-based CGT production
Finance
Gyros Protein Technologies and Cygnus expand collaboration
The extension of the collaboration follows the launch of the ready-to-use Gyrolab CHO HCP and <i>E. coli</i> HCP kits, developed through a licensing and supply agreement with Cygnus
Manufacturing
Mesa Labs acquires Gyros Protein Technologies
The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin its push into biopharmaceutical development
Manufacturing
Gyros Protein Technologies introduces lentivirus titre kit
Ready-to-use kit enabled lentivirus titre determinations during the manufacture of lentivirus vectors
Manufacturing
Gyros Protein Technologies debuts test for impurities in E. coli systems
New product is a host cell protein (HCP) kit for automated impurity analysis of biotherapeutics expressed in <i>E. coli</i> systems
Subscribe now